Literature DB >> 29392360

Hepatic sinusoidal dilatation.

Giuseppe Brancatelli1, Alessandro Furlan2, Alberto Calandra3, Marco Dioguardi Burgio4.   

Abstract

Hepatic sinusoidal dilatation refers to the enlargement of the hepatic capillaries. Most of the time this condition is caused by hepatic venous outflow obstruction, which results in vascular stasis and congestion of hepatic parenchyma. In this setting, hepatic sinusoidal dilatation can be related to pericardial disease, heart failure, compression or thrombosis of the hepatic veins or inferior vena cava (i.e., Budd-Chiari syndrome) or central veins/sinusoids involvement (i.e., sinusoidal obstruction syndrome). Nevertheless, some extrahepatic inflammatory conditions (such as pyelonephritis, cholecystitis, pneumonia, pancreatitis, intestinal bowel disease, and others) may be associated with hepatic sinusoidal dilatation without concurrent venous outflow obstruction. On contrast-enhanced cross-sectional imaging, hepatic sinusoidal dilatation is typically characterized by a mottled, reticular enhancement of the liver, usually referred to as "mosaic" pattern. Other hepatic and extrahepatic imaging features, such us the dilatation of the hepatic veins or the presence of ascites, can help in identifying the cause of sinusoidal dilatation.

Entities:  

Keywords:  Hepatic veins; Liver; Mosaic pattern; Sinusoid

Mesh:

Year:  2018        PMID: 29392360     DOI: 10.1007/s00261-018-1465-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

Review 1.  Chemotherapy-Induced Liver Injury in Patients with Colorectal Liver Metastases: Findings from MR Imaging.

Authors:  Francescamaria Donati; Dania Cioni; Salvatore Guarino; Maria Letizia Mazzeo; Emanuele Neri; Piero Boraschi
Journal:  Diagnostics (Basel)       Date:  2022-03-31

2.  Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol.

Authors:  Cameron G McCarthy; Emily W Waigi; Gagandeep Singh; Thaddaeus R Castaneda; Blair Mell; Saroj Chakraborty; Camilla F Wenceslau; Bina Joe
Journal:  J Pharmacol Exp Ther       Date:  2021-09-14       Impact factor: 4.402

3.  Prophylactic Intra-Uterine β-Cyclodextrin Administration during Intra-Uterine Ureaplasma parvum Infection Partly Prevents Liver Inflammation without Interfering with the Enterohepatic Circulation of the Fetal Sheep.

Authors:  Cathelijne Heymans; Lara R Heij; Kaatje Lenaerts; Marcel den Dulk; Mhamed Hadfoune; Chantal van Heugten; Owen B Spiller; Michael L Beeton; Sarah J Stock; Alan H Jobe; Matthew S Payne; Matthew W Kemp; Boris W Kramer; Jogchum Plat; Wim G van Gemert; Tim G A M Wolfs
Journal:  Nutrients       Date:  2020-05-05       Impact factor: 5.717

Review 4.  Communicating with the hepatobiliary surgeon through structured report.

Authors:  Roberto Cannella; Adele Taibbi; Salvatore Pardo; Giuseppe Lo Re; Ludovico La Grutta; Tommaso Vincenzo Bartolotta
Journal:  BJR Open       Date:  2019-04-29

5.  Acute Liver Failure following a Single Dose of Atezolizumab, as Assessed for Causality Using the Updated RUCAM.

Authors:  Roie Tzadok; Sharon Levy; Jessie Aouizerate; Oren Shibolet
Journal:  Case Rep Gastrointest Med       Date:  2022-03-23

6.  Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis.

Authors:  Linda Calistri; Vieri Rastrelli; Cosimo Nardi; Davide Maraghelli; Sofia Vidali; Michele Pietragalla; Stefano Colagrande
Journal:  World J Gastroenterol       Date:  2021-12-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.